USPTO 2015–2025 USPTO PatentsView US Corporation

Mandos Llc

USPTO PatentsView assignee record - 20 granted patents across 2 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

20
Total patents granted
2
CPC technology areas
21.6
Avg claims per patent
-
5-year filing velocity

The verdict

Mandos holds 20 US patents across 2 technology areas, rank #14,756 of 50,000 tracked assignees.

#14,756
of 50,000 US assignees by volume
Top 17%
by Innovation Score (48.5/100)
21.6
avg claims per patent

Portfolio overview

MANDOS LLC has been granted 20 US utility patents between 2022 and 2025, placing MANDOS LLC at rank #14,756 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.6 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, MANDOS LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 48.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 20 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. MANDOS LLC's 21.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark MANDOS LLC against peers pursuing similar technology classes.

How does MANDOS compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows MANDOS holds 20 patents, placing it at rank #14,756 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

MANDOS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

246810 2022202320242025 3
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
MANDOS LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 6 30.0%
2023 8 40.0%
2024 3 15.0%
2025 3 15.0%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex

Where it ranks

Overall rank by patents

#14,756

Across all tracked assignees

Innovation Score

48.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does MANDOS LLC hold?
MANDOS LLC holds 20 US granted patents filed between 2022 and 2025, spanning 2 technology areas.
What is MANDOS LLC's Innovation Score?
MANDOS LLC has an Innovation Score of 48.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does MANDOS LLC focus on?
MANDOS LLC's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 20 patents. The company has filed patents in 2 CPC subclasses total.
Is MANDOS LLC's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for MANDOS LLC.
What does claim depth mean for MANDOS LLC's patents?
MANDOS LLC's patents average 21.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the MANDOS LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Mandos's 20 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Mandos ranks #14,756 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov